Citigroup’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
PF
NTCM
CI
Citigroup's CLBT Position: Q1 2026 in Review
Citigroup increased its Cellebrite (CLBT) stake by 349% in Q1 2026, buying an estimated $4.34M and bringing the position to 370,091 shares worth $5.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1952.
Citigroup first reported a position in CLBT in Q4 2021 and has held it in 18 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.
- Citigroup held 370,091 shares of Cellebrite worth $5.1M as of Q1 2026.
- Citigroup bought 287,722 Cellebrite shares in Q1 2026, an estimated $4.34M.
- Cellebrite made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #1952 holding.
- Citigroup first reported a position in Cellebrite in Q4 2021 and has held it in 18 quarters since.
- 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.